LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy

被引:12
|
作者
Egranov, Sergey D. [1 ]
Hu, Qingsong [1 ]
Lin, Chunru [1 ,2 ]
Yang, Liuqing [1 ,2 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Long noncoding RNA; antigen presentation; tumour intrinsic factor; Cancer immunology; LONG NONCODING RNA;
D O I
10.1080/15476286.2020.1767455
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long noncoding RNAs (lncRNAs) have been found to associate with all major types of malignancies and play important roles in regulating several hallmarks of cancer by interacting with proteins, DNA, and RNA. The possible functions of lncRNAs and their roles in the regulation of tumour growth will be reported and discussed in the present review. In our recent report, based on genetic mice models and a series of systematic analyses, we suggested that lncRNAs also play critical roles in the regulation of antigen presentation in tumour cells and allow tumour cells to escape immune surveillance, which further broadens the scope of understanding lncRNA functions and how they relate to cancer immunotherapy resistance.
引用
收藏
页码:1625 / 1627
页数:3
相关论文
共 50 条
  • [41] Cancer Cell-intrinsic PD-1 and implications in Combinatorial immunotherapy
    Yao, Han
    Wang, Huanbin
    Li, Chushu
    Fang, Jing-Yuan
    Xu, Jie
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [42] Immunotherapy of cancer with dendritic cell-based tumor vaccines
    Gilboa, E
    Nair, SK
    Morse, M
    Boczkowski, D
    Deng, Y
    Lyerly, HK
    ANNALS OF ONCOLOGY, 1998, 9 : 7 - 7
  • [43] Tumor-dendritic cell fusion as a basis for cancer immunotherapy
    Lee, WT
    Shimizu, K
    Kuriyama, H
    Tanaka, H
    Kjaergaard, J
    Shu, SY
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (05) : 755 - 764
  • [44] Immunotherapy of cancer with dendritic cell-based tumor vaccines
    Gilboa, E
    Nair, SK
    Boczkowski, D
    Mitchel, D
    Faiola, B
    CANCER GENE THERAPY, 1997, 4 (05) : 314 - 314
  • [45] Established breast cancer risk factors and risk of intrinsic tumor subtypes
    Barnard, Mollie E.
    Boeke, Caroline E.
    Tamimi, Rulla M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2015, 1856 (01): : 73 - 85
  • [46] Enhancing tumor T cell infiltration to enable cancer immunotherapy
    Zhang, Jin
    Endres, Stefan
    Kobold, Sebastian
    IMMUNOTHERAPY, 2019, 11 (03) : 201 - 213
  • [47] Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy
    Spranger, Stefani
    Sivan, Ayelet
    Corrales, Leticia
    Gajewski, Thomas F.
    TUMOR IMMUNOLOGY, 2016, 130 : 75 - 93
  • [48] Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor
    Takimoto, Rishu
    Miyashita, Tomoharu
    Mizukoshi, Eishiro
    Kamigaki, Takashi
    Okada, Sachiko
    Lbe, Hiroshi
    Oguma, Eri
    Naitoh, Keiko
    Yasumoto, Kosei
    Makita, Kaori
    Tomita, Katsuro
    Goto, Shigenori
    CYTOTHERAPY, 2020, 22 (06) : 329 - 336
  • [49] Improving cancer immunotherapy by preventing cancer stem cell and immune cell linking in the tumor microenvironment
    Li, Dongyu
    Wang, Lei
    Jiang, Bo
    Jing, Yuchen
    Li, Xuan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [50] The folate pathway inhibitor pemetrexed pleiotropically enhances effects of cancer immunotherapy via immunogenic tumor cell death and T cell-intrinsic mechanisms
    Schaer, David A.
    Amaladas, Nelusha
    Lu, Zhao Hai
    Rasmussen, Erik
    Sonyi, Andreas
    Chin, Darin
    Capen, Andrew
    Li, Yanxia
    Meyer, Catalina
    Jones, Bonita
    Hong, Xiaodong
    Luo, Shuang
    Carpenito, Carmine
    Roth, Kenneth
    Nikolayev, Alexander
    Tan, Bo
    Brahmachary, Manisha
    Chodavarapu, Krishna
    Dorsey, Frank Charles
    Manro, Jason
    Doman, Thompson
    Donoho, Greg
    Surguladze, David
    Hall, Gerald
    Geeganage, Sandaruwan
    Kalos, Michael
    Novosiadly, Ruslan
    CANCER RESEARCH, 2019, 79 (13)